Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types
about
sameAs
Anaplastic lymphoma kinase: signalling in development and diseaseLung cancer cell migration is regulated via repressing growth factor PTN/RPTP β/ζ signaling by meninCorrelation of elevated level of blood midkine with poor prognostic factors of human neuroblastomasMolecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugsALK and ROS1 as targeted therapy paradigms and clinical implications to overcome crizotinib resistanceEmerging importance of ALK in neuroblastomaMidkine in host defenceMidkine and cytoplasmic maturation of mammalian oocytes in the context of ovarian follicle physiologyStructure and function of midkine as the basis of its pharmacological effectsInvolvement of midkine in neuroblastoma tumourigenesisCrystal structure of the ALK (anaplastic lymphoma kinase) catalytic domainFAM150A and FAM150B are activating ligands for anaplastic lymphoma kinaseHigh level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphomaIdentification of midkine as a mediator for intercellular transfer of drug resistanceMolecular pathogenesis of peripheral neuroblastic tumorsPleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolinALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiationAnaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cellsMutation-introduced dimerization of receptor tyrosine kinases: from protein structure aberrations to carcinogenesis.Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesionsTranscriptome profiling of the tubular porcine conceptus identifies the differential regulation of growth and developmentally associated genes.Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor.Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour targetMystic Acetaldehyde: The Never-Ending Story on AlcoholismALK-rearrangements and testing methods in non-small cell lung cancer: a reviewThe synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells.ALK-activating homologous mutations in LTK induce cellular transformation.Signaling receptome: a genomic and evolutionary perspective of plasma membrane receptors involved in signal transduction.Chromogenic in situ hybridization is a reliable assay for detection of ALK rearrangements in adenocarcinomas of the lung.The preclinical profile of crizotinib for the treatment of non-small-cell lung cancer and other neoplastic disorders.Pleiotrophin (PTN) expression and function and in the mouse mammary gland and mammary epithelial cells.The Drosophila midkine/pleiotrophin homologues Miple1 and Miple2 affect adult lifespan but are dispensable for alk signaling during embryonic gut formation.Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome.Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.Pleiotrophin as a central nervous system neuromodulator, evidences from the hippocampus.Identification of anaplastic lymphoma kinase as a potential therapeutic target in Basal Cell CarcinomaTranscriptional factor specificity protein 1 (SP1) promotes the proliferation of glioma cells by up-regulating midkine (MDK).Genetic and functional studies implicate synaptic overgrowth and ring gland cAMP/PKA signaling defects in the Drosophila melanogaster neurofibromatosis-1 growth deficiency.Biological role of anaplastic lymphoma kinase in neuroblastoma.Pleiotrophin commits human bone marrow mesenchymal stromal cells towards hypertrophy during chondrogenesis
P2860
Q24312329-DB170B8D-7F2A-4B15-AC13-82D09D63CEB6Q24339039-66DB90B1-BD2F-4FFC-93C4-FEDBD91DFA5BQ24656678-C6FD3108-8C08-41A8-A234-E13DCF13CB90Q26769659-81B2BE20-3120-428C-B292-E02FDD2B5FBDQ26775347-F0662763-B054-4699-BBD1-B0E7C293639FQ26858819-D5A32E98-6CCE-446B-B109-EC551BFF6FC6Q27010045-CA53DFA6-9ECC-4060-A14E-17970C684211Q27010676-9730BAC4-C065-4795-ADA3-1B6B1C562E89Q27013798-0A27AB31-6B11-440C-861A-424BCB09FFABQ27026748-369C36CE-3265-4FE6-9EB0-670A98523B4FQ27663479-C59FD663-450D-4F90-B9B8-791B40380D34Q28118071-6902EC8F-69EB-4798-8903-077257FDA73CQ28206624-F86964B3-1D93-48FD-9AC8-D9C49CBB0AF3Q28251166-F23923FD-09E5-4165-8DA7-8E689A52611CQ28271405-A162AF83-8712-44EB-87D7-28D49A19C931Q28271787-BA7BDFDA-8CA0-44B6-A49D-4E54F3F8FB6EQ28564190-8A742D03-998C-4E16-B9EB-7EC36FFDC63BQ28571575-05EC91C7-AAC7-4117-A2D1-17358D4A567DQ30372506-3B1ABC3F-A404-46DC-A76F-D7F17A5CD84BQ30909247-C451F826-7E08-491E-AA24-0715C5E2FBF4Q33253603-B572DAE7-F921-4575-B2D3-2147777837ACQ33487136-5F957D6E-2A5E-4851-B4D3-C804AD94ABAFQ33503255-493EB685-EB43-4EB0-A920-6C6435E38133Q33659011-7ACE4997-CD87-4A54-B94C-19E07A8417C9Q33776835-7D509704-8256-4221-B815-3F35CDA9DFF7Q33915644-AE5949D8-07DC-4E38-A392-0E367619C81DQ34162940-3F394D46-A87E-42F3-92F3-B2853A8DCC5EQ34207111-DDAD5443-6AAE-4D73-BB5C-A1D158F6BEA6Q34349164-B6178746-F547-4353-AC31-D58D76FABC18Q34353920-456CC799-DB83-4C02-915F-23E149E82900Q34451087-03BAEF98-D23E-43AD-BD5C-2DA3E19C0776Q34473183-40856A21-73A3-411E-A712-6ABFFF738B8CQ34480771-B155B752-9DDF-4FD6-9969-B84DD8AAB53AQ34552993-29987E20-6F08-4AA3-8A19-5F1B777B28C2Q34869224-DA68D98C-673A-4836-BFE0-FD04C7AFAC34Q35026938-91EA32DD-716D-4207-87E2-24523B73CC14Q35027553-76E8C598-8491-4638-AB2D-3568D4E7C476Q35053088-B73DF9B1-97FE-4505-81BE-AAF4D86B860DQ35084934-B2AC6521-D17B-4B3B-8AF3-0BAB0B62A6D1Q35091670-44D92671-5DDB-4C32-9A5C-740C538049B9
P2860
Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Midkine binds to anaplastic ly ...... actor for different cell types
@ast
Midkine binds to anaplastic ly ...... actor for different cell types
@en
Midkine binds to anaplastic ly ...... actor for different cell types
@nl
type
label
Midkine binds to anaplastic ly ...... actor for different cell types
@ast
Midkine binds to anaplastic ly ...... actor for different cell types
@en
Midkine binds to anaplastic ly ...... actor for different cell types
@nl
prefLabel
Midkine binds to anaplastic ly ...... actor for different cell types
@ast
Midkine binds to anaplastic ly ...... actor for different cell types
@en
Midkine binds to anaplastic ly ...... actor for different cell types
@nl
P2093
P2860
P3181
P356
P1476
Midkine binds to anaplastic ly ...... actor for different cell types
@en
P2093
Angera Kuo
Anna T Riegel
Ciaran Powers
Elaine Buchert Sale
Emma T Bowden
Gerald E Stoica
P2860
P304
35990-35998
P3181
P356
10.1074/JBC.M205749200
P407
P577
2002-07-16T00:00:00Z